Personal information

Other IDs

Scopus Author ID: 55037377300

Activities

Collapse all

Works (22)

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

eClinicalMedicine
2023-07 | Journal article
DOI: 10.1016/j.eclinm.2023.102044
Contributors: Melissa Bersanelli; Elena Verzoni; Alessio Cortellini; Raffaele Giusti; Lorenzo Calvetti; Paola Ermacora; Marilena Di Napoli; Annamaria Catino; Valentina Guadalupi; Giorgia Guaitoli et al.
Source: check_circle
Crossref

Home-Based Management of Patients With Cancer Experiencing Treatment-Induced Toxicities With a Nurse-Led Telephone Triage (the NTT Study)

JCO Oncology Practice
2022-01 | Journal article
DOI: 10.1200/OP.21.00192
Contributors: Lorenzo Calvetti; Marta Tealdo; Francesca Simionato; Gaetana Pagiusco; Roberta Cimenton; Barbara Gasparin; Francesco Corà; Rocco De Vivo; Laura Merlini; Giuseppe Aprile
Source: check_circle
Crossref

Case report: A metabolic complete response to upfront osimertinib in a smoker non-small cell lung cancer patient harbouring egfr g719a/ v769m complex mutation

OncoTargets and Therapy
2020 | Journal article
DOI: 10.2147/OTT.S280933
EID:

2-s2.0-85096502581

Part of ISSN: 11786930
Contributors: Simionato, F.; Calvetti, L.; Cosci, M.; Scarparo, S.; Aprile, G.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience

Oncologist
2020 | Journal article
DOI: 10.1634/theoncologist.2020-0148
EID:

2-s2.0-85087565018

Part of ISSN: 1549490X 10837159
Contributors: Bonanno, L.; Pavan, A.; Ferro, A.; Calvetti, L.; Frega, S.; Pasello, G.; Aprile, G.; Guarneri, V.; Conte, P.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

Advances in Therapy
2020 | Journal article
DOI: 10.1007/s12325-020-01229-w
EID:

2-s2.0-85078863228

Part of ISSN: 18658652 0741238X
Contributors: Russo, A.; Russano, M.; Franchina, T.; Migliorino, M.R.; Aprile, G.; Mansueto, G.; Berruti, A.; Falcone, A.; Aieta, M.; Gelibter, A. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

Expert Opinion on Biological Therapy
2020 | Journal article
DOI: 10.1080/14712598.2020.1724953
EID:

2-s2.0-85079466504

Part of ISSN: 17447682 14712598
Contributors: Pantano, F.; Russano, M.; Berruti, A.; Mansueto, G.; Migliorino, M.R.; Adamo, V.; Aprile, G.; Gelibter, A.; Ficorella, C.; Falcone, A. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

Therapeutic Advances in Medical Oncology
2020 | Journal article
DOI: 10.1177/1758835920968463
EID:

2-s2.0-85094898354

Part of ISSN: 17588359 17588340
Contributors: Bersanelli, M.; Giannarelli, D.; De Giorgi, U.; Pignata, S.; Di Maio, M.; Verzoni, E.; Clemente, A.; Guadalupi, V.; Signorelli, D.; Tiseo, M. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

A validated prognostic classifier for <sup>V600E</sup>BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

European Journal of Cancer
2019 | Journal article
DOI: 10.1016/j.ejca.2019.06.008
EID:

2-s2.0-85069554648

Part of ISSN: 18790852 09598049
Contributors: Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

CK7 and consensus molecular subtypes as major prognosticators in <sup>V600E</sup> BRAF mutated metastatic colorectal cancer

British Journal of Cancer
2019 | Journal article
DOI: 10.1038/s41416-019-0560-0
EID:

2-s2.0-85071460238

Part of ISSN: 15321827 00070920
Contributors: Loupakis, F.; Biason, P.; Prete, A.A.; Cremolini, C.; Pietrantonio, F.; Pella, N.; Dell’Aquila, E.; Sperti, E.; Zichi, C.; Intini, R. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

FLOaTing toward new standards in locally advanced resectable gastroesophageal cancer

Journal of Thoracic Disease
2019 | Journal article
DOI: 10.21037/jtd.2019.12.103
EID:

2-s2.0-85077341207

Part of ISSN: 20776624 20721439
Contributors: Fornaro, L.; Vivaldi, C.; Calvetti, L.; Cappetta, A.; Falcone, A.; Aprile, G.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

Oncologist
2019 | Journal article
DOI: 10.1634/theoncologist.2018-0712
EID:

2-s2.0-85062777878

Part of ISSN: 1549490X 10837159
Contributors: Pasello, G.; Vicario, G.; Zustovich, F.; Oniga, F.; Gori, S.; Rosetti, F.; Bonetti, A.; Favaretto, A.; Toso, S.; Redelotti, R. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Influence and mechanism of lung cavitation development on antiangiogenic therapy: Is cavitation the new caveat?

Translational Lung Cancer Research
2019 | Journal article
DOI: 10.21037/tlcr.2019.08.19
EID:

2-s2.0-85072520876

Part of ISSN: 22264477 22186751
Contributors: Calvetti, L.; Aprile, G.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

Oncologist
2019 | Journal article
DOI: 10.1634/theoncologist.2018-0563
EID:

2-s2.0-85064833138

Part of ISSN: 1549490X 10837159
Contributors: Pavan, A.; Calvetti, L.; Dal Maso, A.; Attili, I.; Del Bianco, P.; Pasello, G.; Guarneri, V.; Aprile, G.; Conte, P.; Bonanno, L.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer

British Journal of Cancer
2019 | Journal article
DOI: 10.1038/s41416-019-0399-4
EID:

2-s2.0-85061393504

Part of ISSN: 15321827 00070920
Contributors: Fornaro, L.; Vivaldi, C.; Parnofiello, A.; Ugolini, C.; Aprile, G.; De Maglio, G.; Pecora, I.; Iacono, D.; Crivelli, F.; Catanese, S. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol

Tumori
2018 | Journal article
DOI: 10.5301/tj.5000704
EID:

2-s2.0-85054987294

Part of ISSN: 20382529 03008916
Contributors: Gardini, A.C.; Faloppi, L.; Aprile, G.; Brunetti, O.; Caparello, C.; Corbelli, J.; Chessa, L.; Bruno, D.; Ercolani, G.; Leonetti, A. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Immunotherapy for colorectal cancer: where are we heading?

Expert Opinion on Biological Therapy
2017 | Journal article
DOI: 10.1080/14712598.2017.1315405
EID:

2-s2.0-85019084692

Part of ISSN: 17447682 14712598
Contributors: Basile, D.; Garattini, S.K.; Bonotto, M.; Ongaro, E.; Casagrande, M.; Cattaneo, M.; Fanotto, V.; De Carlo, E.; Loupakis, F.; Urbano, F. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury

Frontiers in Pharmacology
2017 | Journal article
DOI: 10.3389/fphar.2017.00354
EID:

2-s2.0-85020765770

Part of ISSN: 16639812
Contributors: Cinausero, M.; Aprile, G.; Ermacora, P.; Basile, D.; Vitale, M.G.; Fanotto, V.; Parisi, G.; Calvetti, L.; Sonis, S.T.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study

Frontiers in Pharmacology
2016 | Journal article
DOI: 10.3389/fphar.2016.00331
EID:

2-s2.0-84992150937

Part of ISSN: 16639812
Contributors: D'Aniello, C.; Vitale, M.G.; Farnesi, A.; Calvetti, L.; Laterza, M.M.; Cavaliere, C.; Pepa, C.D.; Conteduca, V.; Crispo, A.; De Vita, F. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer

British Journal of Cancer
2016 | Journal article
DOI: 10.1038/bjc.2015.399
EID:

2-s2.0-84954393384

Part of ISSN: 15321827 00070920
Contributors: Loupakis, F.; Moretto, R.; Aprile, G.; Muntoni, M.; Cremolini, C.; Iacono, D.; Casagrande, M.; Ferrari, L.; Salvatore, L.; Schirripa, M. et al.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

The coming of ramucirumab in the landscape of anti-angiogenic drugs: Potential clinical and translational perspectives

Expert Opinion on Biological Therapy
2015 | Journal article
DOI: 10.1517/14712598.2015.1071350
EID:

2-s2.0-84938840932

Part of ISSN: 17447682 14712598
Contributors: Calvetti, L.; Pilotto, S.; Carbognin, L.; Ferrara, R.; Caccese, M.; Tortora, G.; Bria, E.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Pancreatic cancer: Systemic combination therapies for a heterogeneous disease

Current Pharmaceutical Design
2014 | Journal article
DOI: 10.2174/1381612820666140826154327
EID:

2-s2.0-84911469442

Part of ISSN: 18734286 13816128
Contributors: Melisi, D.; Calvetti, L.; Frizziero, M.; Tortora, G.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier

Molecular characterization into clinical practice: Current status and future perspectives in metastatic non-small-cell lung cancer

Minerva Biotecnologica
2011 | Journal article
EID:

2-s2.0-84857532347

Part of ISSN: 11204826
Contributors: Bonanno, L.; Calvetti, L.; Favaretto, A.; Rosell, R.
Source: Self-asserted source
Lorenzo Calvetti via Scopus - Elsevier
How many people are using ORCID?